Superfund Research Program

Yong Li

Baylor College of Medicine
1102 Bates Street
Suite 530
Houston, Texas 77030
Phone: 713-798-7506
Email: yong.li@bcm.edu

Projects

• Baylor College of Medicine: Administrative Core - Research Translation (2020-2025)

Publications

2021

• Fan C, Qu H, Wang X, Sobhani N, Wang L, Liu S, Xiong W, Zeng Z, Li Y. 2021. Cancer/testis antigens: From serology to mRNA cancer vaccine. Semin Cancer Biol 76:218-231. doi:10.1016/j.semcancer.2021.04.016 PMID:33910064
• Yu X, Li W, Deng Q, Liu H, Wang X, Hu H, Cao Y, Xu-Monette ZY, Li L, Zhang M, Lu Z, Young KH, Li Y. 2021. MYD88 L265P elicits mutation-specific ubiquitination to drive NF-(kappa)B activation and lymphomagenesis. Blood 137(12):1615-1627. doi:10.1182/blood.2020004918 PMID:33025009 PMCID:PMC7995293
• Yu X, Li W, Young KH, Li Y. 2021. Posttranslational modifications in PD-L1 turnover and function: From cradle to grave. Biomedicine 9(11):1702. doi:10.3390/biomedicines9111702 PMID:34829931 PMCID:PMC8615371
• Zhou S, Fan C, Zeng Z, Young KH, Li Y. 2021. Clinical and immunological effects of p53-targeting vaccines. Front Cell Dev Biol 9:762796. doi:10.3389/fcell.2021.762796 PMID:34805170 PMCID:PMC8595300

2020

• Flores-Villanueva P, Sobhani N, Wang X, Li Y. 2020. MR1-restricted T Cells in cancer immunotherapy. Cancers (Basel) 12:doi:10.3390/cancers12082145 PMID:32756356
• Liu M, Wang X, Li W, Yu X, Flores-Villanueva P, Xu-Monette ZY, Li L, Zhang M, Young KH, Ma X, Li Y. 2020. Targeting PD-L1 in non-small cell lung cancer using CAR T cells. Oncogenesis 9:72. doi:10.1038/s41389-020-00257-z PMID:32792499 PMCID:PMC7426958